Samyang Biopharmaceuticals Corp. Increasing Momentum for Its Entry into the Global Aesthetic Market

September 4th, 2020
Samyang Biopharm is pushing for its entry into the global cosmetic market by using its biodegradable suture technology.

Samyang Biopharm. will participate in IMCAS Paris 2020 and will unveil the aesthetic suture brand croquis, which the company has proprietarily developed.
Croquis is a medical absorbable suture used in a procedure designed to improve skin elasticity and reduce wrinkles.

Based on its biodegradable suture technology accumulated for 25 years, Samyang Biopharm developed croquis last year,
which ensured safety based on scientific data, and obtained CE in May.

The brand name croquis comes from a drawing technique of the same name which quickly sketches the characteristics of a model.
It means that Samyang Biopharm’s croquis naturally adjusts the outline of a face and brings out inherent beauty like the drawing croquis technique.

At this event, Samyang Biopharm will actively promote croquis’ safety, efficacy, and technical strengths around the world by presenting the product’s features, procedures, and outcomes through video demo.
In addition, the company will focus on improving croquis’ brand recognition through various methods such as playing videos and posting promotional materials in the venue.